MARKET

BZYR

BZYR

Burzynski Resh Inst Inc
OTCPK
0.0068
NaN%
Opening 09:30 05/21 EDT
OPEN
--
PREV CLOSE
0.0068
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.047
52 WEEK LOW
0.0067
MARKET CAP
893.85K
P/E (TTM)
-0.7010
1D
5D
1M
3M
1Y
5Y
1D
Burzynski Research Warns of SEC Reporting Delinquency Risks
TipRanks · 05/12 21:54
Burzynski Research Institute Consolidates Leadership After CFO Resignation
TipRanks · 04/23 21:32
Burzynski Research Institute, Inc. (BZYR) Quarterly Report (10-Q) for the period ended August 31, 2025
Press release · 10/15/2025 11:40
Weekly Report: what happened at BZYR last week (0908-0912)?
Weekly Report · 09/15/2025 09:44
Weekly Report: what happened at BZYR last week (0901-0905)?
Weekly Report · 09/08/2025 09:45
Weekly Report: what happened at BZYR last week (0825-0829)?
Weekly Report · 09/01/2025 09:43
Weekly Report: what happened at BZYR last week (0818-0822)?
Weekly Report · 08/25/2025 09:47
Weekly Report: what happened at BZYR last week (0811-0815)?
Weekly Report · 08/18/2025 09:44
More
About BZYR
Burzynski Research Institute, Inc. is engaged in the research, production, marketing, promotion and sale of certain medical chemical compounds composed of growth-inhibiting peptides, amino acid derivatives, and organic acids, which are known under the trade name Antineoplastons. Antineoplastons are useful in the treatment of human cancer. The Company is reviewing data from its Phase II clinical trials of Antineoplastons relating to the treatment of various cancers. Antineoplastons are found in the bodily fluids of humans and food. The Company conducted all the Phase II clinical trials for the treatment of a variety of cancers using the combination of Antineoplastons A10 and AS2-1. Clinical trials conducted by the Company primarily use intravenous formulations of Antineoplastons, though few trials also use oral formulations. The Company's clinical trials are conducted at the Burzynski Clinic.

Webull offers Burzynski Research Institute Inc stock information, including OTCPK: BZYR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BZYR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BZYR stock methods without spending real money on the virtual paper trading platform.